Nefazodone Hydrochloride

盐酸奈法唑酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNefazodone Hydrochloride
Drug Alias Namenefazodona奈法唑酮盐酸盐奈法唑酮nefazodonum盐酸萘法唑酮 +[15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressionCocaine-Related DisordersSubstance-Related Disorders
Global Approved IndicationsDepression
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1994/12/22
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDepressionCocaine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeN06AX06